Dogwood Therapeutics Inc. share price logo

Dogwood Therapeutics Inc.

NASDAQ: DWTX

Small Cap

$1.52

-0.03

(-1.94%)

Live

as on

Dogwood Therapeutics Inc. Stock Performance

as on June 23, 2026 at 3:00 am IST

  • Day's Low

    Day's High

    $1.48
    $1.53
    downward going graph

    2.63%

    Downside

    0.66%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.28
    $9.50
    downward going graph

    15.79%

    Downside

    525.00%

    Upside

    downward going graph

Dogwood Therapeutics Inc. share price movements today

Previous Close
$1.55
Open
$1.48
Volume
113.7K
Day's Low - High
$1.48 - $1.53
52 Week Low - High
$1.28 - $9.50

Dogwood Therapeutics Inc. Historical Returns

1 Month Return
-13.41 %
3 Month Return
-48.33 %
1 Year Return
-68.37 %
3 Year Return
0 %
5 Year Return
0 %

Dogwood Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Dogwood Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$52.1M

EPS (TTM)

-0.585

Dividend Yield

0.00%

PE Ratio (TTM)

1.32

Industry PE ratio

-3.921711111111111

PEG Ratio

0

Return On Equity TTM

-34.67%

Dogwood Therapeutics Inc. Stock Valuation

Track how Dogwood Therapeutics Inc. P/E has moved over time to understand its valuation trends.

Dogwood Therapeutics Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-0.40x)

March 31, 2025

Industry (-3.92x)

June 22, 2026

Today (1.32x)

June 22, 2026

Highest (-0.15x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 1.32x

Dogwood Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dogwood Therapeutics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$52.1MNA1.320.00%NA
BUY$37.1B60.79%69.8712.55%NA
BUY$114.6B139.12%26.835.51%NA
BUY$63.9B14.22%14.8829.65%0.59%

Stock Returns calculator for Dogwood Therapeutics Inc. Stock including INR - Dollar returns

The Dogwood Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Dogwood Therapeutics Inc. investment value today

Current value as on today

₹33,923

Returns

-₹66,077

(-66.08%)

Returns from Dogwood Therapeutics Inc. Stock

-₹68,980 (-68.98%)

Dollar Impact

₹2,902 (+2.9%)

Indian Investors' Interest in Dogwood Therapeutics Inc. Stock

Search interest for Dogwood Therapeutics Inc. Stock has decreased by -5% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-5% versus previous 30 day period

Dogwood Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
0
0
0
-
-
-
Operating Income
-1
-1
-1
-2
-7
-4
-3
-15
-3
-5
EBITDA
-1
-1
-1
-2
-7
-10
-3
-15
-3
-4
Interest Expense
-
-
-
-
0
0
-
-
-
-
Depreciation
-
-
-
-
-
0
0
0
-
-
Income Before Tax
-1
-1
-1
-2
-7
-10
-3
-15
-3
-4
Income Tax Expense
-
-
-
-
0
0
0
0
0
0
Net Income
-1
-1
-1
-2
-7
-10
-3
-15
-3
-4
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Dogwood Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
-
-
-
-
0
-
Operating Income
-10
-15
-12
-5
-12
-27
EBITDA
-10
-15
-12
-5
-12
-34
Interest Expense
0
-
-
-
0
-
Depreciation
-
-
-
-
0
0
Income Before Tax
-10
-15
-12
-5
-12
-34
Income Tax Expense
-
-
-
-
0
0
Net Income
-10
-15
-12
-5
-12
-34
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Dogwood Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-1
-1
-2
-7
-10
-3
-15
-3
-4
Operating Cash Flow
0
0
0
-6
-4
-4
-3
-3
-4
Investing Cash Flow
-
-
-
3
-
-
-
-
-
Financing Cash Flow
-
1
0
15
7
0
-
0
11
Change in Cash
0
0
0
12
2
-4
-3
-3
6

Dogwood Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-2
-10
-15
-12
-5
-12
-34
Operating Cash Flow
-2
-3
-15
-11
-4
-8
-15
Investing Cash Flow
-
-
-
-
-
3
-
Financing Cash Flow
2
33
0
4
1
16
7
Change in Cash
0
29
-15
-6
-3
11
-8

Global Institutional Holdings in Dogwood Therapeutics Inc.

Funds
Holdings
Northern Trust Corp
0.07%
The Goldman Sachs Group Inc
0.04%
BNP Paribas Arbitrage, SA
0%
Barclays PLC
0%
Urban Wealth Management, LLC
0%

Insights on Dogwood Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Dogwood Therapeutics, Inc. Common Stock has experienced a drawdown of -96.3%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 74.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 88.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, DWTX stock has moved down by -48.3%

About Dogwood Therapeutics Inc.

Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a combination of famciclovir and celecoxib that has completed Phase 2b clinical trial to treat fibromyalgia; Halneuron, which is in Phase 2b clinical trial for the treatment of chemotherapy-induced neuropathic pain and cancer pain, as well as pre-clinical trial for acute surgical pain; and IMC-2, a combination of valacyclovir and celecoxib intended to synergistically suppress herpesvirus activation; and Serpin Peptide 16 that is in early Phase 1 development to reduce neuropathy secondary to treat chemotherapeutic agents that are neurotoxic. The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024. The company was founded in 2012 and is based in Alpharetta, Georgia.
OrganisationDogwood Therapeutics Inc.
Headquarters44 Milton Avenue, Alpharetta, GA, United States, 30009
IndustryBiotechnology
CEOMr. Gregory Duncan
E-voting on sharesClick here to vote

Key Management of Dogwood Therapeutics Inc.

Name

Title

Mr. Gregory Duncan

Chairman & CEO

Ms. Angela Walsh

CFO, Secretary & Treasurer

Dr. R. Michael Gendreau M.D., Ph.D.

Chief Medical Officer

Dr. William L. Pridgen M.D.

Founder & Member of Scientific Advisory Board

Mr. Ralph D. Grosswald M.P.H.

Senior Vice President of Operations

Ms. Carol Duffy Ph.D.

Chief Scientific Advisor

FAQs

What is Dogwood Therapeutics Inc. share price today?

Dogwood Therapeutics Inc. share price today is $1.52 as on . Dogwood Therapeutics Inc. share today touched a day high of $1.53 and a low of $1.48.

What is the 52 week high and 52 week low for Dogwood Therapeutics Inc. share?

Dogwood Therapeutics Inc. share touched a 52 week high of $9.5 on and a 52 week low of $1.28 on . Dogwood Therapeutics Inc. stock price today i.e. is trending at $1.52,which is 84.00% down from its 52 week high and 18.75% up from its 52 week low.

What is Dogwood Therapeutics Inc.'s market capitalisation today?

Dogwood Therapeutics Inc. market capitalisation is $0.00T as on .

How to invest in Dogwood Therapeutics Inc. Stock (DWTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Dogwood Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dogwood Therapeutics Inc. Shares that will get you 0.9868 shares as per Dogwood Therapeutics Inc. share price of $1.52 per share as on June 22, 2026 at 9:30 pm IST.

What is the minimum amount required to buy Dogwood Therapeutics Inc. Stock (DWTX) from India?

Indian investors can start investing in Dogwood Therapeutics Inc. (DWTX) shares with as little as ₹94.68 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.80 in Dogwood Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Dogwood Therapeutics Inc. share’s latest price of $1.52 as on June 22, 2026 at 9:30 pm IST, you will get 6.5789 shares of Dogwood Therapeutics Inc.. Learn more about fractional shares .